Sarnoff Corporation

Intuity Medical, Inc.

Sri International

David Sarnoff Research Center, Inc.

Orchid Biosciences, Inc.

Rosedale Medical, Inc.

Other

Sterling Eduard McBride

Peter John Zanzucchi

Satyam Choudary Cherukuri

Pamela Kay York

Christopher C Gregory

John Gregory Aceti

Richard Morgan Moroney, Iii

Alexei Guennadievich Tsekoun

Joseph H Abeles

Robert Richard Demers

Alan Michael Braun

Judith Ann Ladd

Keith James Hanna

Barry Jay Thaler

Robert L Quinn

William Happer

Stephen Charles Hsu

James Regis Matey

Aaron W Levine

Robert Amantea

Winston Kong Chan

Richard Sita

Steven A Lipp

Michael Gillis Kane

Timothy James Davis

Rajan Kumar

Mark F Schutzer

William Chiang

David Norman Ludington

Richard Patrick Wildes

Charlotte A Burton

Michael G Kane

Zhonghui Hugh Fan

Ralph Doud Whaley, Jr

Alex Krasner

Christina Marie Knoedler

Paul Leonard Braun

Raymond Joseph Kolczynski

Jane Circle Asmuth

Paul James Heaney

John P Riganati

Bryan Lloyd Bentz

William Yat Chiang

Richard Moroney

Paul L Brown

Richard Morgan Iii Moroney

Christopher Carter Gregory

An integrated circuit having Radio Frequency Identification components and circuitry used for authentication is discussed. The RFID components and circuitry include two or more coils and corresponding electrical circuits that are tuned to use two or more different resonant frequencies including: a first resonant RF used for power generation and a second resonant RF used for data communication. The integrated circuit contains a unique signature that is used for the authentication with two or more aspects including i) a first aspect that is a programmed password in a memory embedded on the integrated circuit, and ii) a second aspect that is a unique, randomly generated code based upon a physical characteristic of the integrated circuit.

Authentication apparatus, system and methods using unclonable identifiers

The invention relates to analyte monitoring/drug (pharmaceutical agent) delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The electronics portion includes a processor and associated circuitry (e.g., memory, supporting electronics and the like), a motor or the like, a sensor, a power supply (e.g., battery) and optionally an interface. In general, the processor controls the operation of the device and is data communication with the actuator, motor, sensor and interface. The invention provides for autonomous operation, that is, without intervention of the user. The invention can optionally provide for calibration without intervention of the user. The invention can also provide for semi-continuous monitoring for day and night time. The invention can provide for up to four, or more, weeks of operation. The invention can provide for a device that is relative small in size, and therefore unobtrusive. The invention can also provide for device with remote control and interactive electronics. The invention may be also used for the delivery of various pharmaceutical agents including high potency drugs to minimize patient intervention and minimize discomfort.

Autonomous, ambulatory analyte monitor or drug delivery device

The invention relates to analyte monitoring/drug delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The invention can optionally provide for calibration without intervention of the user and can also provide for semi-continuous monitoring for day and night time. The invention can provide up to four, or more, weeks of operation. The invention can provide for a device that is relatively small in size, and therefore unobtrusive. The invention can also provide for device with remote control and interactive electronics. The invention may be also used for the delivery of various pharmaceutical agents.

Arrangements for the detection of the presence and/or concentration of an analyte in a sample of bodily fluid include diffuse transmission, diffuse reflection and edge or waveguide illumination arrangements. A vertical flow assay arrangement and/or technique is also disclosed, and includes a detection component that can be in the form of an array of optical detection elements. A number of assay pad constructions are described which may include at least one or more of the following components: a prefilter component, a reflective component, a membrane component, a reagent component, a mesh component, and a component to prevent lateral spreading.

Analyte concentration detection devices and methods

The present invention provides a system and method for achieving a calibration-free primary atomic clock standard operating at the 0-0 transition free-atom frequency, thus creating a primary frequency standard, with attributes that include scalable to chip-scale dimensions and power consumption.

System and method for modulating pressure in an alkali-vapor cell

A cell suitable for use with an atomic clock and a method for making the same, the cell including: a silicon wafer having a recess formed therein; at least one amorphous silicate member having an ion mobility and temperature expansion coefficient approximately that of silicon sealing the recess; and, an alkali metal containing component and buffer gas contained in the recess. The method includes: providing a silicon wafer; forming a cavity through the silicon wafer; introducing an alkali metal containing component and buffer gas into the cavity; and, anodically bonding at least one amorphous silicate member having an ion mobility and temperature expansion coefficient approximately that of silicon to the wafer to close the cavity.

Anodically bonded cell, method for making same and systems incorporating same

A method and apparatus for configuring and tuning a crystal by selectively controlling a fluid supplied to a plurality of nodes within a substrate. The apparatus comprises a substrate having at least one node that can be selectively supplied with a liquid that will change the material property of the node. The node may be a spherical cavity in a three-dimensional structure, a cylindrical aperture in two-dimensional structure, or a cavity in a one-dimensional structure. The node or nodes in the substrate are coupled to a fluid distribution assembly that selectively alters the material property of the nodes. The material property may be changed by moving the fluid or material in a fluid, using electrohydrodynamic pumping, electroosmotic pumping, electrophoresis, thermocapillarity, electrowetting or electrocapillarity. The change in the material property in at least one of the nodes changes the electromagnetic radiation filtering or switching characteristics of the crystal.

Method and apparatus for configuring and tuning crystals to control electromagnetic radiation

A microfluidic fluid delivery system includes a microfluidic chip having a fluid input. A fluid reservoir is coupled to the fluid input. A gas delivery system has a gas pressure source and a variable amplitude function generator generating an alternating signal. A valve is coupled to the function generator and the gas pressure source. The valve controls the gas pressure pulse in response to said alternating signal. The gas pressure pulse displaces fluid from the fluid reservoir into the fluid input.

Fluid delivery system for a microfluidic device using alternating pressure waveforms

A microfluidic fluid delivery system includes a microfluidic device having a fluid input. A fluid reservoir is fluidically coupled to the fluid input. A gas delivery system has a pulse generator that generates an electric pulse. An electrically operated valve is coupled to the pulse generator and the gas pressure source. The valve controls the gas pressure pulse in response to said electric pulse. The gas pressure pulse displaces fluid from the fluid reservoir into the plurality of capillaries.

Fluid delivery system for a microfluidic device using a pressure pulse

Apparatus for separating molecules

Growing community of inventors

Princeton, NJ, United States of America

Sterling Eduard McBride